27th April 2008
The Company was notified today that Mr. Kevin Steeds and Mr. Mark Scott, both directors of the Company, each bought on 27th April 2007 5,000 ordinary shares of 10 pence in the Company (“Ordinary Shares”) at a price of 142 pence per Ordinary Share. Following these purchases, Mr. Steeds’ and Mr. Scott’s beneficial interests in the Company have both risen to 690,010 Ordinary Shares, each representing 1.93 per cent. of the Company’s total issued ordinary share capital.
Further to the above Mark Scott also transferred on 27th April 2007 141,350 Ordinary Shares to his SIPP at a price of 141.5 pence per Ordinary Share. There is no change to Mr. Scott’s beneficial interest as a result of this transfer.
On 27th April, under the Cello Group Performance Share Plan (“PSP”) Kevin Steeds and Mark Scott were each granted matching awards of options entitling them to acquire 5,000 ordinary shares of 10p at an exercise price of 10p per share as a result of their having elected to receive an equal number of Cello shares in lieu of a proportion of their cash bonuses, net of tax and national insurance. These options will normally be exercisable from 27th April 2011 subject to continued employment and ownership of the shares so acquired and the extent to which performance conditions have been met.
In addition, on 16th April 2007, under the PSP, other Cello employees were granted options entitling them to acquire a total of 10,000 ordinary shares of 10p at an exercise price of 10p per share. These shares will normally be exercisable from 16th April 2011 subject to continued employment and the extent to which performance conditions have been met.
Phone 020 7812 8468
Cello Health plc
8-9 Queen Street
8-9 Queen Street
in England no.05120150